Moderna : 2024 ESCMID (mRNA-1010) - MarketScreener
Safety and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine in Healthy Adults Mieke Soens, Raffael...
Source: marketscreener.com
Active Comparator News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Active Comparator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Active Comparator Today - Breaking & Trending Today
TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...
Source: prnewswire.com
UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care
21 scientific presentations, including 7 late breakers, showcase the breadth of UCB's portfolio, reinforcing commitment to improving the lives of people living...
Source: prnewswire.com
THE CANADIAN INFLAMMATORY BOWEL DISEASE RESEARCH CONSORTIUM AWARDS FIRST $1M PIONEER GRANT FROM TAKEDA CANADA
/CNW/ - The Canadian Inflammatory Bowel Disease Research Consortium (CIRC) awards the inaugural $1 million PIONEER Grant from Takeda Canada Inc. (Takeda), in...
Source: newswire.ca
AbbVie Provides Update Regarding SKYRIZI® (risankizumab-rzaa) for the Treatment of Moderate to Severe Crohn's Disease in the U.S.
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has extended its review period for SKYRIZI®...
Source: prnewswire.com